CNS Response to Establish "Center of Excellence" for rEEG(SM) Application,
Research and Development
COSTA MESA, Calif., Oct. 26 /PRNewswire-FirstCall/ -- CNS Response, Inc. (OTC Bulletin Board: CNSO) announced today has it signed a letter of intent to acquire the Neuro-Therapy Clinic, P.C., a neuropsychiatric clinic in Denver, Colorado. Established in 1993, Neuro-Therapy Clinic, P.C. is a center for highly-advanced testing and treatment of neuropsychiatric problems, including learning, attentional and behavior challenges, mild head injuries, as well as depression, anxiety, bipolar and all other common psychiatric disorders. Acquisition terms were not disclosed. CNS anticipates the completion of the deal to occur within 90 days.
"The Neuro-Therapy Clinic is clearly amongst the leaders in utilizing the most advanced neuropsychiatry tools in patient assessment and treatment. Use of Referenced-EEG in guiding pharmaco-therapy has been a core competency of this clinic for over three years. In fact, the clinic has been a key contributor to the large outcomes database which comprises the backbone of our rEEG(SM) platform," noted Len Brandt, chairman and CEO of CNS Response. "Through this acquisition, CNS Response will be able to advance neurophysiology data collection, beta-test planned technological advances in rEEG(SM), advance physician training in rEEG(SM) and investigate practice- development strategies associated with rEEG(SM). Our long-standing relationship with the Neuro-Therapy Clinic and its key personnel gives us confidence that we will accomplish this vision."
Neuro-Therapy Clinic, P.C. is owned and operated by Daniel Hoffman, M.D. Upon Board approval, Dr. Hoffman will be appointed Chief Medical Officer of CNS Response.
About CNS Response
CNS Response is a life-sciences data company focused on the
commercialization of the first patented commercial system that guides
psychiatrists and other physicians
|SOURCE CNS Response, Inc.|
Copyright©2007 PR Newswire.
All rights reserved